Авторы

  • Баховадинов Б.Б., Певцов Д.Э., Эстрина М.А., Кучер М.А, Кулагин А.Д.
  • Ашурзода Г.С.
  • Шумилина О.В., Мурадов А.А.
  • Кубиддинов А.Ф., Одиназода А.А.
  • Обидова М.М.

Ключевые слова:

связанное с трансфузией острое повреждение легких, распространенность, профилактика.

Библиографические ссылки

Аграненко В. А. Дифференциальная диагностика гемотрансфузионных осложнений // Вестник службы крови России.—2001.—№ 1.—С. 17–21.

Бирюкова Л.С. Современная тактика лечения посттрансфузионных осложнений // Гематология и трансфузиология.—2001.—№ 5.—С. 23–29.

Баховадинов Б. Б., Ашурова Г. С., Кучер М. А. и другие. О случаях трансфузионно–ассоциированого повреждения легких в клинической практике //«Ученые Записки». – 2015. –Том XXII·– № 3. – С. 29–35.

Баховадинов Б.Б., Ашурзода Г.С., Одиназода А.А., Додхоева М.Ф., Барышев Б.А. О частоте трансфузионно–ассоцированного повреждения легких в акушерской практике // Трансфузиология. 2022– Том. XXIII, №2, пр. 1. С. 8–10.

Васильев Д.А., Ценципер Л.М. и другие. Трансфузионно–ассоциированное повреждение легких//Анестезиология и реаниматология. – 2017. – №3 (63). –Р. 240–242.

Клиническое использование эритроцитсодержащих компонентов донорской крови. Клинические рекомендации /Б.А. Аксельрод, Е.Н. Балашова, А.Е. Баутин и др. // Гематология и трансфузиология.—2018.—T.63., № 4.—P.372–435.

Падалко А.А., Жежер А.А., Ващук Ф.С. и др. TRALI–синдром в акушерстве // Медицина неотложных состояний.‒2016.‒№3.‒С.101‒

Руководство Совета Европы по приготовлению, использованию и гарантии качества компонентов крови. Европейский директорат по качеству лекарственных средств и здравоохранению (EDQM), 21 изд., 2023. С. 459

Солдатенков В.Е., Чечеткин А.В., Минеева Н.В., Бессмельцев С.С.и др. Клинико–лабораторная диагностика реакций и осложнений, связанныхс трансфузией донорскойкрови и ее компонентов, в учреждениях здравоохранения. Методические рекомендации. ФМБА России. Санкт–Петербург, 2020. С.36.

Трансфузиология: Национальное руководство / под ред. проф. А.А. Рагимова.—М.: ГЭОТАР–Медиа, 2018.— С. 2091.

Annual Serious Hazards of Transfusion (SHOT) report 2017. https://www.shotuk.org/wp–content/uploads/myimages/SHOT–Report–2017–WEB–Final–v4–25–9–18.pdf. Accessed 1 Оctober 2018.

Barnard RD. Indiscriminate transfusion: acritique of case reports illustrating hyper–sensitivity reactions. NY State J Med.1951;51(20):2399–2402 Brittingham TE. Immunologic studiesonleukocytes.VoxSang.1957;2(4):242–248.

Bakhovadinov B.B., Kucher M.A., Ashurzoda G.S., Kubiddinov A.F., Odinazoda A.A. Transfusion reactions frequency in the Republic of Tajikistan. Vox Sanguinis. 2023;118(Suppl. 1):6–379 (348–349). DOI: 10.1111/vox.13433

Beck T.N., Young N.G., Erickson M.L. et al. Rare antibody–associated hemolytic transfusion reaction and transfusion–related acute lung injury: a case report. BMCSurg., 2017, Apr. 26. vol. 17, no.1, pp.48.

Boffard K.D., Riou B., Warren B. et al. Recombinant factor V11a as adjunctive therapy for bleeding control in severely injured trauma patients: Two parallel randomized, placebo–controlled, double–bind clinical trials. J. Trauma, 2005, no. 59, pp.8–15.

Cajic O., Rana R., Winters J.I. et al. Transfusion–related acute lung injury in the critically ill. Prospective nested case–control study. Am. J. Respir. Crit. Care Med., 2007, 176, pp.886–891.

Curtis B.R., McFarland J.G. Mechanisms of transfusion–related acute lung injury (TRALI): anti–leukocyte antibodies// Crit. Care Med. — 2006. — № 34. — Р. 118–S123.

Fatalities Reported to Food and Drug Administration (FDA) Following Blood Collection and Transfusion; Annual summary for fiscal year 2016. https://www.fda.gov/downloads/BiologicsBloodVaccines/Vlaar AP, Juffermans NP. Transfusion–relate-dacutelunginjury:aclinicalreview.Lancet. 2013; 382 (9896):984–994.

Goldman M., Webert K.E., Arnold D.M., Freedman J., Hannon J., Blajchman M.A. Proceeding sofa consensus conference: towards an understanding of TRALI//Transfus.Med.Rev.—2005.— 19. — Р.2–31.

Guide to the preparation, use and quality assurance of blood components // European Directorate for the quality of medicines and healthcare (EDQM).—Council of Europe,2017.—P.23–440.

Juffermans NP,Vlaar AP. Possible TRALI is a real entity. Transfusion. 2017;57(10):2539–2541.

Kazanegra R., Cheng V., Garcia A. et al. A rapid test for B–type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study // J. Card Fail. — 2001. — № 7. — Р.21–9.

Kleinman S. A perspective on transfusion–related acute lung injury two years after the Canadian Consensus Conference // Transfusion. — 2006. — № 46. — P. 1465–8.

Kopko P.M. Leukocyte antibodies andbiologically active mediators in the pathogenesis of transfusion–related acute lung inger. Curr. Hematol. Rep., 2004, no.3, pp. 456–461.

Kopko P.M., Marshall C.S., MacKenzie M.R.Transfusion–related acute lung injury: report of clinical look–back investigation //JAMA.–2000.– Vol.287.–P.1968–1971.

Kopko P.M., Marshall C.S., MacKenzie M.R. et al. Transfu– sion related acute lung injury: report of a clinical look–back investigation//JAMA.—2002.—№287.—Р.1968–1971.

Krishnaswamy P., Lubien E., Clopton P. et al. Utility of B–natriuretic peptide levels in identifying patients with left ventricular systolicordiastolicdysfunction//Am.J.Med.—2001.—№111.— Р.274–9.

Maisel A.S., Krishnaswamy P., Nowak R.M. et al. Rapid measurement of B–type natriuretic peptide in the emergency diagnosis ofheartfailure // N.Engl.J.Med.—2002.—№347.—Р.161–7.

Maisel A.S., Koon J., Krishnaswamy P. et al. Utility of B–natriuretic peptide as a rapid, point–of–care test for screening patients un– dergoing echocardiography to determine left ventricular dysfunction// Am. Heart J. — 2001. — № 141. — Р.367–74.

Marik P.E., Howard L.C. Acute lung injury following blood transfusion: expanding the definition. Crit.Care Med., 2008, vol.36, no.11, pp.3080–3084.

Muller M.C., Juffermans N.P. Transfusion–related acute lung injury: A preventable syndrome? Exp. Rev.Hematol., 2012, no.5, pp. 97–106.

Mu¨ller M.C., van Stein D, Binnekade J.M., van Rhenen D.J.,Vlaar A.P. Low–risk transfusion–related acute lung injury donor strategies and the impact on the onset of transfusion–related acute lung injury: a meta–analysis. Transfusion. 2015; 55(1): 164–175.

Moore S.B. Transfusion–related acute lung injury (TRALI): clinical presentation, treatment and prognosis // Crit.Care Med.–2006.–№5.–Р.114–117.

Nguyen X.D., Schulze T.J., Bugert P. et al. Granulocyte antibodies in male blood donors: can they trigger transfusion–related acute lung injury? Transfusion, 2018, vol. 58, no. 8, pp. 1894–1901.

Peters A.L., van Hezel M.E., Juffermans N.P.,Vlaar A.P. Pathogenesis of non–antibody mediated transfusion–related acute lung injury from bench to bedside. Blood Rev. 2015;29(1):51–61.

Peters A.L., Van Stein D., Vlaar A.P. Antibody–mediated transfusion–related acute lung injury; from discovery to prevention. Br J Haematol. 2015;170(5):597–614.

Peak D.K., Davis W.T., Walton S.B. Late presentation of transfusion–related acutelunginjuryintheemergencydepartment. Clin. Pract. Cases Emerg. Med., 2019, Jan 7, pp.33–35.

Philipps E., Fleischner F.G. Pulmonary edema in the course of a blood transfusion without overloading the circulation. DisChest. 1966; 50(6): 619–623.

Politis C., Wiersum J.C., Richardson C. et al. The international haemovigilance network database for the surveillance of adverse reactions and events in donors and recipients of blood components: Technical issues and results. Vox. Sand.,2016, no. 111, pp.409–417.

Popovsky M.A. Transfusion–related acute lung injury // Curr. Opin. Hematol. — 2000. — № 7. — P. 402–407.

Popovsky M.A., Abel M.D., Moore S.B. Transfusion–related acute lung injury asso–ciated with passive transfer of antileukocyte antibodies. AmRevRespirDis.1983;128(1):185–189.

Popovsky M.A., Audet A.M., Andrzejewski C.Jr. Transfusion–associated circulatory overload in orthopedic surgery patients: a multi–institutional study. Immunohematology.1996;12(2):87–89.

Popovsky M.A., Moore S.B. Diagnostic and pathogenetic considerations in transfusion–related acute lung injury // Transfusion.— 1985. — № 25. — Р.573–577.

Rana R., Fernandez–Perez E.R., Khan S.A. et al. Transfusion–related acute lung injury and pulmonary edema in critically ill patients: a retrospective study // Transfusion. — 2006. — № 46. — Р. 1478–83.

Sandler S.G., HanS., Langeberg A. et al. Nonhemolytic passenger lymphocyte syndrome. Transfusion, 2017, Dec., 57(12), pp. 2942–2945.

Semple JW, Rebetz J, Kapur R. Transfusion–associated circulatory overload (TACO): Time to shed light on the pathophysiology. ISBT Sci Ser. 2018; ISBTSci Ser. 2019;14(1):136–139.

Silliman C.C., Bjornsen A.J., Wyman T.H. et al. Plasma and lipids from stored platelets cause acute lung injury in an animal model. Transfusion, 2003, no.43, pp. 633–640.

Silliman C.C., Boshkov L.K., Mehdizadehkashi Z. et al. Trans– fusion related acute lung injury: epidemiology and a prospective analysis of etiologic factors // Blood.—2003.—№101.—Р.454–462.

Thompson JS, Severson CD, Parmely MJ, Marmorstein BL, Simmons A. Pulmonary “hypersensitivity” reactions induced by transfusion of non–HL–A leukoagglutinins. N Engl J Med. 1971;284(20): 1120–1125.

Toy P., Gajic O., Bacchetti P. et al. Transfusion–Related Acute Lung Injury: Incident and Risk Factors. Blood, 2012, no.119, pp. 1757–1767.

Toy P., Popovsky M.A., Abraham E. et al. Transfusion–related acute lung injury: definition and review // Crit. Care Med. — 2005. — № 33. — P. 721–6.

Toy P, Bacchetti P, Grimes B, et al. Recipient clinical risk factors predominate in possible transfusion–related acute lung injury. Transfusion. 2015;55(5):947–952.

Toy P, Kleinman SH, Looney MR. Proposed revised nomenclature for transfusion–related acute lung injury. Transfusion. 2017; 57(3): 709–713.

The 2013 AABB Blood Collection, Utilization, and Patient Blood Management Survey Report Report. AABB, December 18, 2015. – P.77.

van Stein D, Beckers EA, Peters AL, et al. Underdiagnosing of antibody–mediated transfusion–related acute lung injury: evaluation of cellular–based versus bead–based techniques. VoxSang. 2016; 111(1): 71–78.

Vlaar AP, Binnekade JM, Prins D, et al. Risk factors and outcome of transfusion–related acute lung injury in the critically ill: a nestedcase–control study. Crit Care Med. 2010; 38(3): 771–778

Wallis J.P. et al. Single hospital experience of TRALI // Transfusion. — 2003. — № 43. — Р. 1053–9.

Ward HN. Pulmonary infiltrates associated with leukoagglutinin transfusion reactions. Ann Intern Med.1970;73(5):689–694.

Wiersum–Osselton J.C. et al. Transfusion–related acute lung injury (TRALI) in the Netherlands in 2002–2005 // Ned Tijdschr.Geneeskd. — 2008. — № 152. — Р. 1784–8.

Zhiburt E.B., Protopopova E.B., Gubanova M.N. et al. Circulatory overload – a new complication of blood transfusion. Transfuziologiya, 2016, no.3, pp. 75–89. (InRuss.)